HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glenn M Marshall Selected Research

reversan

8/2011ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
8/2009Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Glenn M Marshall Research Topics

Disease

73Neoplasms (Cancer)
01/2022 - 09/2003
67Neuroblastoma
01/2022 - 03/2003
23Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 06/2002
18Carcinogenesis
01/2022 - 07/2003
7Breast Neoplasms (Breast Cancer)
09/2021 - 07/2003
6Leukemia
01/2021 - 06/2002
6Residual Neoplasm
08/2015 - 02/2003
4Melanoma (Melanoma, Malignant)
11/2020 - 10/2014
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 09/2015
3Neoplasm Metastasis (Metastasis)
08/2016 - 04/2014
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014 - 02/2012
2Skin Neoplasms (Skin Cancer)
09/2019 - 02/2012
2Lung Neoplasms (Lung Cancer)
04/2014 - 05/2009
2Infections
09/2012 - 10/2002
2Glucocorticoid Receptor Deficiency
10/2010 - 05/2007
1Neurofibrosarcoma (MPNST)
02/2021
1Chronic Disease (Chronic Diseases)
09/2020

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2003
18Pharmaceutical PreparationsIBA
01/2022 - 04/2006
10Histone Deacetylase InhibitorsIBA
09/2021 - 06/2006
10Small Interfering RNA (siRNA)IBA
08/2016 - 10/2006
9Oncogene Proteins (Oncogene Protein)IBA
04/2021 - 02/2010
8RetinoidsIBA
08/2015 - 03/2003
7Biological ProductsIBA
09/2021 - 06/2002
7EnzymesIBA
04/2021 - 09/2007
6Vincristine (Oncovin)FDA LinkGeneric
01/2022 - 06/2002
6MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
6Transcription Factors (Transcription Factor)IBA
09/2021 - 07/2010
6N-Myc Proto-Oncogene ProteinIBA
01/2021 - 06/2011
6Long Noncoding RNAIBA
11/2019 - 01/2014
5RNA (Ribonucleic Acid)IBA
01/2022 - 07/2014
5Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 11/2007
5Messenger RNA (mRNA)IBA
10/2020 - 01/2014
4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
4PolyaminesIBA
04/2021 - 12/2008
4Tripartite Motif ProteinsIBA
05/2016 - 02/2012
4multidrug resistance-associated protein 1IBA
08/2009 - 01/2004
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
11/2021 - 06/2007
3VorinostatFDA Link
09/2021 - 11/2012
3Drug CombinationsIBA
01/2021 - 08/2016
3Carrier Proteins (Binding Protein)IBA
11/2019 - 11/2009
3Eflornithine (Ornidyl)FDA Link
01/2019 - 12/2008
3Indicators and Reagents (Reagents)IBA
01/2018 - 02/2003
3DNA (Deoxyribonucleic Acid)IBA
10/2016 - 09/2007
3Dexamethasone (Maxidex)FDA LinkGeneric
09/2015 - 05/2007
3Folic Acid (Vitamin M)FDA LinkGeneric
06/2015 - 06/2010
3Antisense OligonucleotidesIBA
07/2014 - 09/2003
3Histones (Histone)IBA
10/2010 - 05/2006
3Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2006 - 03/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 08/2009
2Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 06/2015
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
04/2021 - 01/2019
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2020 - 05/2007
2Protein Isoforms (Isoforms)IBA
11/2020 - 02/2010
2CrizotinibIBA
01/2020 - 01/2019
2PanobinostatIBA
01/2019 - 01/2016
2CationsIBA
01/2019 - 09/2016
2VemurafenibIBA
08/2016 - 10/2014
2Conditioned Culture MediaIBA
02/2016 - 11/2009
2ChromatinIBA
11/2015 - 05/2009
2Isotretinoin (Accutane)FDA LinkGeneric
08/2015 - 12/2012
2VitaminsIBA
12/2014 - 06/2010
2reversanIBA
08/2011 - 08/2009
2Adenosine Triphosphate (ATP)IBA
08/2011 - 06/2010
2Sirtuin 1IBA
06/2011 - 03/2009
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
10/2010 - 05/2007
2Protein Glutamine gamma Glutamyltransferase 2IBA
02/2010 - 11/2007
2retinoic acid receptor betaIBA
05/2009 - 06/2006
2Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
05/2009 - 03/2003
2TubulinIBA
02/2008 - 10/2006
2LigandsIBA
12/2005 - 03/2003
1ruxolitinibIBA
11/2021
1Adrenergic Agents (Adrenergic Drugs)IBA
09/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2021
1Mitogen-Activated Protein KinasesIBA
02/2021
1UbiquitinIBA
01/2021
1Ubiquitin-Specific ProteasesIBA
01/2021
1lambda Spi-1IBA
01/2021
1carfilzomibIBA
01/2021
1PolyubiquitinIBA
01/2021
1OTX015IBA
01/2021
1CateninsIBA
01/2021
1SE486-11IBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1Proteasome InhibitorsIBA
01/2021
1Phosphotransferases (Kinase)IBA
12/2020
1withaferin AIBA
11/2020
1ponatinibIBA
10/2020
1Tyrosine Kinase InhibitorsIBA
10/2020
1Lapatinib (GW572016)FDA Link
10/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2020
1Arachidonic Acid (Vitamin F)IBA
05/2020

Therapy/Procedure

37Therapeutics
01/2022 - 02/2003
16Drug Therapy (Chemotherapy)
01/2022 - 02/2003
4Precision Medicine
01/2022 - 01/2018
2Stem Cell Transplantation
02/2015 - 09/2013
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Salvage Therapy
02/2021
1Immunotherapy
11/2020
1Length of Stay
09/2020